Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Journal of Translational Medicine, 2025Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis
Guo H., Gao J., Gong L. et al.
Olink Explore 3072/384
European Journal of Preventive Cardiology, 2025Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence
Li J., Lai Y., Jiang C. et al.
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation
Guo X., Shi W., Lu J. et al.
Olink Target 96
American Journal of Physiology-Heart and Circulatory Physiology, 2025Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis
Goñi-Olóriz M., Garaikoetxea Zubillaga M., San Ildefonso-García S. et al.
Cell, 2025Systems-level immunomonitoring in children with solid tumors to enable precision medicine
Chen Q., Zhao B., Tan Z. et al.
Archives of Gerontology and Geriatrics, 2025Causal relationship between gut microbiota and ageing: A multi-omics Mendelian randomization study
Zhang G., Lu Y., Wang Z. et al.
Cell Death & Disease, 2025ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFRα+ cancer-associated fibroblasts during hepatocarcinogenesis
Bai H., Zhu X., Gao L. et al.
Biological Psychiatry, 2025MAPPING THE CEREBROSPINAL FLUID PROTEOME IN BIPOLAR DISORDER
Göteson A., Holmén-Larsson J., Celik H. et al.
Alzheimer's & Dementia, 2025Plasma proteomic biomarkers as mediators or moderators for the association between poor cardiovascular health and white matter microstructural integrity: The UK Biobank study
Beydoun M., Beydoun H., Noren Hooten N. et al.
Brain Sciences, 2025A Pilot Proteomic Analysis of Huntington’s Disease by Functional Capacity
McGarry A., Moaddel R.
The Lancet Oncology, 2025Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
Chong W., Low J., Tay J. et al.
Olink Explore HT
Discover Oncology, 2025Combination of inflammatory proteins in serum can be used to diagnose papillary thyroid carcinoma with lymph node metastasis
Pan Y., Wang G., Chen D. et al.
Aging Cell, 2025Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV
Navas A., Matzaraki V., van Eekeren L. et al.
Scientific Reports, 2025Proteomic, metabolomic and lipidomic profiles in community acquired pneumonia for differentiating viral and bacterial infections
Rischke S., Gurke R., Zielbauer A. et al.
Nature Communications, 2025Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure
Peterson T., Hahn V., Moaddel R. et al.
Scientific Reports, 2025Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate
Jia M., Lin L., Yu H. et al.
Anesthesiology, 2025Protein alterations in patients with delirium after cardiac surgery: An exploratory case-control sub-study of the VISION Cardiac Surgery Biobank
Spence J., Devereaux P., Bashir S. et al.
Journal of Hepatology, 2025AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials
Armisen J., Rauschecker M., Sarv J. et al.
Cell Reports Medicine, 2025Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy
Komaki H., Takeshita E., Kunitake K. et al.
Scientific Reports, 2025The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies
Smits H., Delemarre E., Pandit A. et al.
3478 publications
Items per page
1821-1840 of 3478 publications